Lacosamide Oral Solution
Product Images NDC 68999-885

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 68999-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Governmental & Specialty Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Lacosamide Oral Solution 10ml Cup Label)

Lacosamide Oral Solution USP C-V label delivering 10 mL with a concentration of 100 mg/10 mL. The label includes storage instructions to not freeze and is for institutional use only. Manufactured for Chartwell Governmental & Specialty RX, LLC, Congers, NY. Contains a barcode, lot number, expiration date, and prescription only notation.*

FDA Label Image

"image Description" (Lacosamide Oral Solution 5ml Cup Label)

Lacosamide Oral Solution, USP C-V label showing a 50 mg/5 mL concentration and a 5 mL delivered dose. The label includes the NDC 68999-885-05, states 'Do Not Freeze,' and is marked for institutional use only. Manufactured for Chartwell Governmental & Specialty RX, LLC, Congers, NY.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 1)

A bar chart depicting percent seizure reduction compared to baseline in three studies, labeled Study 2, Study 3, and Study 4. Each study compares placebo with Lacosamide at various dosages, showing higher seizure reduction percentages for Lacosamide groups versus placebo groups.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 2)

A cumulative response rate curve graph comparing lacosamide oral solution at doses of 200 mg/day, 400 mg/day, and 600 mg/day versus placebo. The vertical axis shows the responder rate from worsening to improvement, and the horizontal axis shows the percent of patients. The graph illustrates efficacy trends across different dosage groups and placebo in a patient population.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 3)

Kaplan-Meier survival curve comparing the proportion of patients remaining relapse-free over time (days) between placebo (N=121) and Lacosamide oral solution (N=118, 10 mg/mL) groups. The graph includes number at risk counts and statistical data including p-value (0.001) and hazard ratio (0.548) with confidence intervals.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Structure)

Chemical structure diagram of lacosamide, the active ingredient in Lacosamide Oral Solution 10 mg/mL by Chartwell Governmental & Specialty RX, LLC. The structure illustrates the molecular composition and arrangement of atoms characteristic of lacosamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.